Haiyan Cai

913 total citations
35 papers, 687 citations indexed

About

Haiyan Cai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Haiyan Cai has authored 35 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Haiyan Cai's work include Ubiquitin and proteasome pathways (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Haiyan Cai is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). Haiyan Cai collaborates with scholars based in China, Thailand and United Kingdom. Haiyan Cai's co-authors include Aiwu Zhou, Ting Xu, Fei Zhang, Jiawei Wu, Hudie Wei, Yugang Wang, Pilin Wang, Xiaoyong Jiang, Xiaoxiao Wang and Yu Bai and has published in prestigious journals such as Journal of Biological Chemistry, Cell Metabolism and Cancer Research.

In The Last Decade

Haiyan Cai

32 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiyan Cai China 14 408 270 171 154 47 35 687
Erica L. Bradshaw‐Pierce United States 19 577 1.4× 288 1.1× 71 0.4× 91 0.6× 56 1.2× 25 982
Dehua Lu China 16 311 0.8× 165 0.6× 59 0.3× 109 0.7× 17 0.4× 29 575
Francis P. Barbone United States 14 323 0.8× 134 0.5× 121 0.7× 121 0.8× 20 0.4× 16 629
Tianyu Wang China 14 193 0.5× 310 1.1× 44 0.3× 127 0.8× 51 1.1× 33 551
Emily E. Brown United States 13 639 1.6× 90 0.3× 132 0.8× 115 0.7× 50 1.1× 20 887
Y Uehara Japan 17 609 1.5× 212 0.8× 88 0.5× 190 1.2× 39 0.8× 23 889
Michelle L. Kraus United States 7 466 1.1× 447 1.7× 63 0.4× 101 0.7× 38 0.8× 9 1.1k
Karin Larsson Sweden 12 525 1.3× 144 0.5× 135 0.8× 99 0.6× 33 0.7× 28 831
Lynn Ueno United States 9 630 1.5× 221 0.8× 38 0.2× 126 0.8× 42 0.9× 13 910

Countries citing papers authored by Haiyan Cai

Since Specialization
Citations

This map shows the geographic impact of Haiyan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Cai more than expected).

Fields of papers citing papers by Haiyan Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Cai. The network helps show where Haiyan Cai may publish in the future.

Co-authorship network of co-authors of Haiyan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Cai. A scholar is included among the top collaborators of Haiyan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Cai. Haiyan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Hao, Hao Peng, Haiyan Cai, et al.. (2025). USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ. Cell Death and Differentiation. 2 indexed citations
2.
Gao, Xuejie, Liangning Hu, Ke Hu, et al.. (2024). EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma. Acta Biochimica et Biophysica Sinica. 56(7). 1055–1064. 1 indexed citations
3.
Zhang, Hui, Bo Li, Ke Hu, et al.. (2024). Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma. Archives of Biochemistry and Biophysics. 754. 109929–109929. 2 indexed citations
4.
Ge, Meng-Kai, Cheng Zhang, Na Zhang, et al.. (2023). The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency. Cell Metabolism. 35(12). 2216–2230.e8. 33 indexed citations
5.
Li, Xia, Xuehong Zhang, Qianqian Yin, et al.. (2023). Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells. Cancer Research. 84(3). 479–492. 4 indexed citations
6.
Xu, Zhijian, Hui Zhang, Dandan Yu, et al.. (2023). Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma. Archives of Biochemistry and Biophysics. 747. 109771–109771. 3 indexed citations
7.
8.
Ma, Chunmin, Meng Liu, Jiong Zhang, et al.. (2021). ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway. Chemico-Biological Interactions. 351. 109770–109770. 3 indexed citations
9.
Yang, Le, Jing Zheng, Zhen Zou, et al.. (2020). Human serum albumin as an intrinsic signal amplification amplifier for ultrasensitive assays of the prostate-specific antigen in human plasma. Chemical Communications. 56(12). 1843–1846. 13 indexed citations
10.
Gao, Han, Haiyan Cai, Jia Liu, et al.. (2020). Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody. Cell Discovery. 6(1). 79–79. 9 indexed citations
11.
Chen, Xiangyun, Xingming Zhang, Haiyan Cai, et al.. (2019). Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid. Cancer Letters. 469. 277–286. 31 indexed citations
12.
Luo, Hao, Bo Jing, Yu Xia, et al.. (2019). WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell International. 19(1). 56–56. 26 indexed citations
13.
Wang, Yingying, Linlin Wu, Haiyan Cai, et al.. (2018). YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells. Cell Death Discovery. 4(1). 44–44. 13 indexed citations
14.
Jing, Bo, Meng Liu, Li Yang, et al.. (2017). Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro. Acta Pharmacologica Sinica. 39(3). 492–498. 40 indexed citations
15.
Wei, Hudie, Haiyan Cai, Jiawei Wu, et al.. (2016). Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism. Journal of Biological Chemistry. 291(48). 24900–24911. 9 indexed citations
16.
Cai, Haiyan, Qiufeng Liu, Dingding Gao, et al.. (2014). Novel fatty acid binding protein 4 (FABP4) inhibitors: Virtual screening, synthesis and crystal structure determination. European Journal of Medicinal Chemistry. 90. 241–250. 29 indexed citations
17.
Cai, Haiyan, Ting Wang, Peng Sun, et al.. (2013). Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice. Acta Pharmacologica Sinica. 34(11). 1397–1402. 27 indexed citations
18.
Liu, Yang, Jianping Fang, Haiyan Cai, et al.. (2012). Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors. Bioorganic & Medicinal Chemistry. 20(18). 5473–5482. 17 indexed citations
19.
Cai, Haiyan, Zhijian Xu, Jie Tang, et al.. (2012). The essential role for aromatic cluster in the β3 adrenergic receptor. Acta Pharmacologica Sinica. 33(8). 1062–1068. 6 indexed citations
20.
Cai, Haiyan, et al.. (2010). Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening. Bioorganic & Medicinal Chemistry Letters. 20(12). 3675–3679. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica L. Bradshaw‐Pierce Breakdown of academic impact, for papers by Dehua Lu Breakdown of academic impact, for papers by Francis P. Barbone Breakdown of academic impact, for papers by Tianyu Wang Breakdown of academic impact, for papers by Emily E. Brown Breakdown of academic impact, for papers by Y Uehara Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Karin Larsson Breakdown of academic impact, for papers by Lynn Ueno
Rankless by CCL
2026